He did mention he UK and the transition of Illicit "non Legal" users over to Legal Customers.
What was of interest was also the Endometriosis "Capsulate" New Products in Development that seemed to indicate no Competition at all in that space.
Plus BXN have a regulatory barrier that can take years of time to meet the regulatory requirements and large Capital Outlay to play catch up to BXN it was an example of a Commercial Moat,,, in the past Big Business have been shown to pay a Premium for the front runners in any emerging Industry.
I was fortunate to Buy into the Canadian Green market and invested in the some of the first 36 Canadian Companies to gain licenses, then the Canadian Govt decided lets stop with licenses until we can monitor what cause and effect would be the result ,, that then drove up the value of the first 36 and then Big Business just bought the top 3 for a premium and through scale went on to dominate the Canadian market..
When I look at BXN , if I were big business then BXN would be my target for Market Entry into the Industry.. NZT
BXN Price at posting:
2.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)